Avacta Group PLC

(AVCTF)

By |

Profile

Avacta Group PLC is a United Kingdom-based biotechnology company. The company offers its products through three segments that are Diagnostics, Therapeutics, and Animal Health. The company is developing novel cancer immunotherapies combining its two proprietary platforms Affimer biotherapeutics and preCISION tumor-targeted chemotherapy. The company operates in the United Kingdom, Rest of Europe, Asia, and North America.

Contact Information

Website: www.avacta.com
Email: investors@avacta.com
Main Phone: +44 1904217070
Address: Unit 20, Ash Way
Address 2: Thorp Arch Estate
City / Town: Wetherby
Country: GB
Postal Code: LS23 7FA

Issuer Information

Exchange: GREY
CEO: David Alastair MacLaughlin Smith
Employees: 112

Equities News

Profile

Avacta Group PLC is a United Kingdom-based biotechnology company. The company offers its products through three segments that are Diagnostics, Therapeutics, and Animal Health. The company is developing novel cancer immunotherapies combining its two proprietary platforms Affimer biotherapeutics and preCISION tumor-targeted chemotherapy. The company operates in the United Kingdom, Rest of Europe, Asia, and North America.

Contact Information

Website: www.avacta.com
Email: investors@avacta.com
Main Phone: +44 1904217070
Address: Unit 20, Ash Way
Address 2: Thorp Arch Estate
City / Town: Wetherby
Country: GB
Postal Code: LS23 7FA

Issuer Information

Exchange: GREY
CEO: David Alastair MacLaughlin Smith
Employees: 112

Equities News

$ 2.38 $ 0. (0.00%)
Last Price 2.38 Change $ 0. Change % 0.00 Tick N/A
Bid N/A Bid Size 0.00 Ask N/A Ask Size 0.00
Open N/A High N/A Low N/A Prev Close 2.38
Last Trade Volume 0 52 Wk Hi 2.41 52 Wk Low 1.37
Market Cap 601.3 mi Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 252,649,804.00 EPS (TTM) -0.15 PE Ratio N/A Exchange Greys